Locally applied HRT to be available without prescription

Postmenopausal women will be soon able to access a low dose Hormone Replacement Therapy (HRT) product from their local chemist without prescription, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced.

Gina 10 microgram vaginal tablets (containing estradiol) are used for the treatment of vaginal symptoms such as dryness, soreness, itching, burning and uncomfortable sex caused by oestrogen deficiency in postmenopausal women aged 50 years and above who have not had a period for at least 1 year. This product is locally-applied, meaning it is inserted into the vagina and not taken orally.

The decision to reclassify these vaginal tablets follows a safety review by the MHRA, independent advice from the Commission on Human Medicines (CHM), and a public consultation. The UK regulator sought views from patients, pharmacists, prescribers and a wide range of stakeholders including the Royal College of Obstetricians & Gynaecologists, the Faculty of Sexual & Reproductive Healthcare, the British Pharmacopoeia Commission and the British Menopause Society.

Low-dose vaginal estradiol has been widely used for the treatment of postmenopausal vaginal symptoms as a prescription medicine since 1991 and has a well-established safety profile. The product will be supplied from a pharmacy when it is considered safe and suitable to do so, following consultation with a pharmacist.

Pharmacists are trained healthcare professionals. They will have access to training materials and a checklist that will enable them to advise women on whether these low dose vaginal tablets are appropriate and safe for them to use and to give the information they need, so they can make informed choices. Other vaginal tablets that also contain estradiol, including Vagifem 10 microgram vaginal tablets, will still be available on prescription.

 

We’re putting women’s health to the top of the agenda – our Women’s Health Strategy published today is testament to that. More widely we’re continuing to work with suppliers and manufacturers to secure sustainable short-term and long-term access to HRT and our UK-wide menopause taskforce will tackle taboos and issues surrounding menopause.

Minister for Health, Maria Caulfield

Editor at  | Website |  + posts

Workplace Wellbeing Professional is an online magazine featuring news and analysis on a broad range of employee wellbeing topics, focused on a UK based audience.

Share

Latest News

Latest Analysis

Related Articles

Jo Ellen Grzyb: How Emojis and Abbreviations Fuel Misunderstandings Between Generations in the Workplace

Typical communication styles vary widely across generations; research revealed that 90% of UK teams experience conflicts stemming from digital tools.

Festive Burnout Takes Toll on Wellbeing as Workers Struggle to Switch Off

Rising end-of-year stress is leaving many employees exhausted and prompting calls for employers to support recovery and reflection over the holidays.

Four Wellbeing Trends Set to Reshape Workforces in 2026

Global research warns that overwork and burnout will continue to harm performance unless employers make resilience and wellbeing central to workforce strategy.

Half of UK Employees ‘Would Leave Job Over Poor Bereavement Support’

A new study suggests that bereavement support is becoming a central wellbeing issue for UK organisations.